What is Matinas BioPharma Holdings, Inc.'s Market Cap?

Matinas BioPharma Holdings, Inc.'s Market Cap is $2.7M, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s Enterprise Value?

Matinas BioPharma Holdings, Inc.'s Enterprise Value is $1.9M, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s EV / EBITDA?

Matinas BioPharma Holdings, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s Net Income (TTM)?

Matinas BioPharma Holdings, Inc.'s Net Income (TTM) is -$6.7M, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s EBITDA?

Matinas BioPharma Holdings, Inc.'s EBITDA is -$6.7M, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s Diluted EPS (TTM)?

Matinas BioPharma Holdings, Inc.'s Diluted EPS (TTM) is -0.46, based on as-reported figures from SEC (XBRL) filings.

What is Matinas BioPharma Holdings, Inc.'s Net Debt?

Matinas BioPharma Holdings, Inc.'s Net Debt is -$755.0K, based on as-reported figures from SEC (XBRL) filings.

Matinas BioPharma Holdings, Inc. (MTNB) Financial Statements

Matinas BioPharma Holdings, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG005WX2XH7

XASE · usd

0.18▲ 0.00 (0.93%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.18

Day's Range0.18 – 0.19

52-Week Range0.17 – 2.14

Volume367.1K

Avg Volume1.9M

Share Statistics

Shares Outstanding

Employees2

ExchangeXASE

Listed2014-07-21

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Matinas BioPharma Holdings, Inc. (MTNB)

What is Matinas BioPharma Holdings, Inc.'s Market Cap?: Matinas BioPharma Holdings, Inc.'s Market Cap is $2.7M, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s Enterprise Value?: Matinas BioPharma Holdings, Inc.'s Enterprise Value is $1.9M, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s EV / EBITDA?: Matinas BioPharma Holdings, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s Net Income (TTM)?: Matinas BioPharma Holdings, Inc.'s Net Income (TTM) is -$6.7M, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s EBITDA?: Matinas BioPharma Holdings, Inc.'s EBITDA is -$6.7M, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s Diluted EPS (TTM)?: Matinas BioPharma Holdings, Inc.'s Diluted EPS (TTM) is -0.46, based on as-reported figures from SEC (XBRL) filings.
What is Matinas BioPharma Holdings, Inc.'s Net Debt?: Matinas BioPharma Holdings, Inc.'s Net Debt is -$755.0K, based on as-reported figures from SEC (XBRL) filings.